WE
TGTX icon

Wealth Effects’s TG Therapeutics TGTX Stock Holding History

Wealth Effects’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$399K Hold
12,000
– – 0.14% 133
2025
Q4 		$358K Hold
12,000
– – 0.11% 137
2025
Q3 		$434K Buy
12,000
+1,000
+9% +$32.9K 0.14% 121
2025
Q2 		$396K Sell
11,000
-500
-4% -$18.6K 0.15% 117
2025
Q1 		$453K Sell
11,500
-3,000
-21% -$101K 0.19% 106
2024
Q4 		$436K Hold
14,500
– – 0.16% 117
2024
Q3 		$339K Sell
14,500
-2,000
-12% -$43.7K 0.12% 148
2024
Q2 		$294K Hold
16,500
– – 0.11% 150
2024
Q1 		$251K Buy
16,500
+2,500
+18% +$39.8K 0.09% 172
2023
Q4 		$239K Sell
14,000
-1,500
-10% -$17.4K 0.09% 185
2023
Q3 		$130K Buy
+15,500
New +$216K 0.06% 177

Other funds holding TGTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return